Low concentration of topical cyclosporin A for severe alopecia areata

P. D. Pigatto, M. M. Montalbano, R. Cirillo, N. Mozzanica, G. F. Altomare, A. F. Finzi

Research output: Contribution to journalArticle

Abstract

The results of a trial on 59 patients with severe alopecia areata involving more than 30% of the scalp are reported. Topical 0.2% cyclosporin A treatment appears to be more useful than placebo and in addition has no relevant side effects. Cyclosporin A appeared to be a reasonable therapeutic option for severe alopecia areata even though a recurrence cannot yet be prevented, so that the follow-up at 6 to 12 months showed no differences between treatment and placebo.

Original languageEnglish
Pages (from-to)377-382
Number of pages6
JournalAnnali Italiani di Dermatologia Clinica e Sperimentale
Volume42
Issue number4
Publication statusPublished - 1988

ASJC Scopus subject areas

  • Dermatology

Fingerprint Dive into the research topics of 'Low concentration of topical cyclosporin A for severe alopecia areata'. Together they form a unique fingerprint.

  • Cite this

    Pigatto, P. D., Montalbano, M. M., Cirillo, R., Mozzanica, N., Altomare, G. F., & Finzi, A. F. (1988). Low concentration of topical cyclosporin A for severe alopecia areata. Annali Italiani di Dermatologia Clinica e Sperimentale, 42(4), 377-382.